Planet 13 Holdings (PLNH) Return on Capital Employed (2022 - 2026)
Planet 13 Holdings' (PLNH) quarterly Return on Capital Employed came in at 45.49% in Q1 2026, down 2412.0% year-on-year from 1.97% in Q1 2025, and down 1.47% on a QoQ basis from 44.83% in Q4 2025.
Planet 13 Holdings (PLNH) Return on Capital Employed (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Return on Capital Employed data on file, last reported at 45.49% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 2412.0% year-over-year to 45.49% in Q1 2026; TTM through Mar 2026 was 45.49%, a 2412.0% decrease from a year earlier, with the FY2025 full-year figure at 37.92%, down 1484.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 45.49%, down from 44.83% in the prior quarter.
- Over the last five years, Return on Capital Employed for PLNH reached as high as 2.91% in Q3 2022 and fell as low as 53.07% in Q3 2023.
- Historically, Return on Capital Employed has averaged 28.39% across 5 years, with a median of 24.36% in 2023.
- Across the five-year window, Return on Capital Employed slumped 5016 bps in 2023 and soared 4322 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 21.54% in 2022, then tumbled by 100 bps to 43.14% in 2023, then surged by 59 bps to 17.8% in 2024, then sank by 152 bps to 44.83% in 2025, then dropped by 1 bps to 45.49% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 45.49% in Q1 2026, 44.83% in Q4 2025, and 51.99% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -45.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.49% |
| Dec 31, 2025 | -44.83% |
| Sep 30, 2025 | -51.99% |
| Jun 30, 2025 | -23.88% |
| Mar 31, 2025 | -21.37% |
| Dec 31, 2024 | -17.80% |
| Sep 30, 2024 | -9.85% |
| Jun 30, 2024 | -36.56% |
| Mar 31, 2024 | -43.64% |
| Dec 31, 2023 | -43.14% |
| Sep 30, 2023 | -53.07% |
| Jun 30, 2023 | -25.99% |
| Mar 31, 2023 | -24.36% |
| Dec 31, 2022 | -21.54% |
| Sep 30, 2022 | -2.91% |
| Jun 30, 2022 | -3.82% |
| Mar 31, 2022 | -12.46% |